BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33313411)

  • 1. CCTs as new biomarkers for the prognosis of head and neck squamous cancer.
    Dong Y; Lu S; Wang Z; Liu L
    Open Med (Wars); 2020; 15(1):672-688. PubMed ID: 33313411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Characterization of Expression Profiles and Prognostic Values of the Eight Subunits of the Chaperonin TRiC in Breast Cancer.
    Xu WX; Song W; Jiang MP; Yang SJ; Zhang J; Wang DD; Tang JH
    Front Genet; 2021; 12():637887. PubMed ID: 33815471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Power of a Chaperonin Containing TCP-1 Subunit Genes Panel for Hepatocellular Carcinoma.
    Li W; Liu J; Zhao H
    Front Genet; 2021; 12():668871. PubMed ID: 33897772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
    Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
    Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spermine synthase (
    Pan X; Xue L; Sun Y
    Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.
    Gao W; Zhang ZW; Wang HY; Li XD; Peng WT; Guan HY; Liao YX; Liu A
    Front Genet; 2022; 13():895281. PubMed ID: 35754792
    [No Abstract]   [Full Text] [Related]  

  • 7. The expression and methylation of
    Zhao Y; Zhao J; Zhong M; Zhang Q; Yan F; Feng Y; Guo Y
    Front Genet; 2022; 13():982241. PubMed ID: 36204311
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive analysis of the expression of chaperonin containing TCP1 subunits (CCTs) and their influence on prognosis in hepatocellular carcinoma.
    Fu R; Jiang S; Guan Z; Li J; Zhang X; Chen H
    Transl Cancer Res; 2020 Mar; 9(3):1867-1883. PubMed ID: 35117534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of NUTF2 as a Candidate Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
    Zhang R; Gao Y
    Onco Targets Ther; 2021; 14():5455-5467. PubMed ID: 35221694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.
    Ma C; Li H; Li X; Lu S; He J
    Biomark Med; 2019 Nov; 13(16):1399-1415. PubMed ID: 31596126
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of the Nerve-Cancer Cross-Talk-Related Prognostic Gene Model in Head and Neck Squamous Cell Carcinoma.
    Li J; Xu Y; Peng G; Zhu K; Wu Z; Shi L; Wu G
    Front Oncol; 2021; 11():788671. PubMed ID: 34912722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic expansion of chaperonin-containing TCP-1 (CCT/TRiC) complex subunits yields testis-specific isoforms required for spermatogenesis in planarian flatworms.
    Counts JT; Hester TM; Rouhana L
    Mol Reprod Dev; 2017 Dec; 84(12):1271-1284. PubMed ID: 29095551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the Therapeutic and Prognostic Role of the CD8+ T Cell-Related Gene ALDH2 in Head and Neck Squamous Cell Carcinoma.
    Zhang H; Li Z; Zheng Y
    Cancer Inform; 2022; 21():11769351221139252. PubMed ID: 36570380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma.
    Feng C; Jin X; Han Y; Guo R; Zou J; Li Y; Wang Y
    Med Sci Monit; 2020 Oct; 26():e926800. PubMed ID: 33099569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.
    Liu J; Wu Y; Wang Q; Liu X; Liao X; Pan J
    Future Oncol; 2018 Feb; 14(5):449-459. PubMed ID: 29322815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of expression and prognostic significance for MCM family in head and neck squamous cell carcinoma.
    Sun E; Peng L; Liu Z; Yan Z; Chen M; Zheng J
    Histol Histopathol; 2024 Apr; 39(4):471-482. PubMed ID: 37526267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
    Wang L; Jia Y; Jiang Z; Gao W; Wang B
    Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
    Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
    Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma.
    Cui K; Yao X; Wei Z; Yang Y; Liu X; Huang Z; Huo H; Tang J; Xie Y
    Front Genet; 2022; 13():917344. PubMed ID: 36186458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.